
Drugs giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mbGLD7
via
IFTTT
0 comments:
Post a Comment